Pharmacotherapy of aphasia: myth or reality?

Détails

ID Serval
serval:BIB_178E451F1FD4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Pharmacotherapy of aphasia: myth or reality?
Périodique
Brain and Language
Auteur(s)
de Boissezon X., Peran P., de Boysson C., Démonet J.F.
ISSN
0093-934X (Print)
ISSN-L
0093-934X
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
102
Numéro
1
Pages
114-125
Langue
anglais
Notes
Publication types: Journal Article ; ReviewPublication Status: ppublish. PDF type: Brief communication
Résumé
Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were associated with speech therapy.
Mots-clé
Amphetamine/therapeutic use, Aphasia/drug therapy, Aphasia/etiology, Bromocriptine/therapeutic use, Cholinesterase Inhibitors/therapeutic use, Clinical Trials as Topic, Dopamine Agents/therapeutic use, Fluoxetine/therapeutic use, GABA Agonists/therapeutic use, Humans, Indans/therapeutic use, Neuroprotective Agents/therapeutic use, Paroxetine/therapeutic use, Physostigmine/therapeutic use, Piperidines/therapeutic use, Piracetam/therapeutic use, Pyridines/therapeutic use, Serotonin/therapeutic use, Serotonin Uptake Inhibitors/therapeutic use, Stroke/complications
Pubmed
Web of science
Création de la notice
24/03/2013 19:52
Dernière modification de la notice
03/03/2018 14:19
Données d'usage